N8-(3-(DIMETHYLAMINO)PROPYL)-N1-ETHYL-6-(2-PROPENYL)-ERGOLINE-1,8-DICARBOXAMIDE, (8.BETA.)-
UNII 3LCV6MB85B
Substance Identification & Data
This profile provides standardized clinical and technical data for N8-(3-(dimethylamino)propyl)-n1-ethyl-6-(2-propenyl)-ergoline-1,8-dicarboxamide, (8.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3LCV6MB85B.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 166533-36-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H37N5O2 IRQIOIBAVPLXLF-KJXAQDMKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N8-(3-(dimethylamino)propyl)-n1-ethyl-6-(2-propenyl)-ergoline-1,8-dicarboxamide, (8.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.